- Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal diseaseChris Tikellis
Division of Diabetic Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
Curr Opin Nephrol Hypertens 20:62-8. 2011..Angiotensin-converting enzyme 2 (ACE2) has recently emerged as a key regulator of the renin-angiotensin system in both health and disease...
- Direct antiatherosclerotic effects of PPAR agonistsKarin A M Jandeleit-Dahm
Diabetes Division, Albert Einstein JDRF Centre for Diabetes Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
Curr Opin Lipidol 20:24-9. 2009..The purpose of this review is to evaluate the currently available evidence for a direct vasculoprotective effect of PPAR agonists...
- Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetesChris Tikellis
Baker IDI Heart and Diabetes Institute, PO Box 6492, Melbourne, Australia
Clin Sci (Lond) 124:617-26. 2013....
- Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetesChris Tikellis
Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Central, Melbourne 8008, Australia
Clin Sci (Lond) 123:519-29. 2012....